Secondary prevention with clopidogrel after TIA or stroke;Secundaire preventie met clopidogrel na TIa of herseninfarct

Nederlands Tijdschrift voor Geneeskunde

Volumn 157, Issue 27, 2013, Pages

  Zuurbier, S M ^a,b   Vermeer, Sarah E ^a,c   Hilkens, Pieter H E ^a,d   Algra, Ale ^a,d   Roos, Yvo B W E M ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE;

ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR ACCIDENT; COMBINATION CHEMOTHERAPY; DRUG COST; DRUG EFFICACY; HUMAN; MONOTHERAPY; NETHERLANDS; PRACTICE GUIDELINE; SECONDARY PREVENTION; TRANSIENT ISCHEMIC ATTACK; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

EID: 84880245514     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Algra A. Digestion of the antiplatelets comparison of PRoFESS: 18-7=1? Stroke. 2009; 40: 1932-5.
2. Kwaliteitsinstituut voor de gezondheidszorg CBO, Nederlands Huisartsen Genootschap. Multidisciplinaire richtlijn Cardiovasculair risicomanagement, herziening 2011. Houten: Bohn Stafleu van Loghum; 2011.
3. Kwaliteitsinstituut voor de gezondheidszorg CBO, Nederlandse Vereniging voor Neurologie. Richtlijn Diagnostiek, behandeling en zorg voor patiënten met een beroerte. Utrecht: Nederlandse Vereniging voor Neurologie; 2008.
4. NHG-standaard TIA. Utrecht: Nederlands Huisartsen Genootschap; 2004.
5. NHG-standaard CVA. Utrecht: Nederlands Huisartsen Genootschap; 2004.
6. Wiersma T, namens de werkgroep TIA. Addendum bij de NHG-standaard TIA; voortaan ook dipyridamol. Huisarts Wet. 2006; 49: 671.
7. Halkes PHA. Acetylsalicylzuur-dipyridamol effectiever dan alleen acetylsalicylzuur bij de secundaire preventie na een 'transient ischaemic attack' of een herseninfarct van arteriële oorsprong; de 'European/Australasian stroke prevention in reversible ischaemia trial' (ESPRIT). Ned Tijdschr Geneeskd. 2006; 150: 1832-8.
8. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42: 227-76.
9. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008; 25: 457-507.
10. Perk J, De BG, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis. 2012; 223: 1-68.
11. ESPRIT Study Group, Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006; 367: 1665-73.
12. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996; 348: 1329-39.
13. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004; 364: 331-7.
14. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006; 354: 1706-17.
15. Hankey GJ, Johnston SC, Easton JD, et al. Efect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. Int J Stroke. 2011; 6: 3-9.
16. Sacco RL, Diener HC, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008; 359: 1238-51.
17. Tijs V, Lemmens R, Fieuws S. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke. Eur Heart J. 2008; 29: 1086-92.
18. Farmacotherapeutisch Kompas. www.fk.cvz.nl, geraadpleegd op 28 februari 2013.
19. Wang Y, Johnston SC Rationale and design of a randomized, doubleblind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. Am Heart J. 2010; 160: 380-6.
20. Wang Y. Clopidogrel and aspirin versus aspirin alone for the treatment of high-risk patients with acute non-disabling cerebrovascular event (CHANCE); A randomized, double-blind, placebo-controlled multicenter trial [oral presentation]. International Stroke Conference; 2013.
21. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial. http://clinicaltrials.gov/ct2/show/NCT00991029, geraadpleegd op 29 april 2013.
22. Holmes MV, Perel P, Shah T, Hingorani A.D., Casas J P. CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta analysis. JAMA. 2011; 306: 2704-14.
23. Bennett CL, Connors JM, Carwile JM, et al. Trombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med. 2000; 342: 1773-7.
24. Korte W, Cattaneo M, Chassot PG, et al. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Trombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (OGARI) and the Working Group Trombosis of the European Society for Cardiology (ESC). Tromb Haemost. 2011; 105: 743-9.
25. Juurlink DN, Gomes T, Mamdani MM, Gladstone D.J., Kapral MK The safety of proton pump inhibitors and clopidogrel in patients after stroke. Stroke. 2011; 42: 128-32.